James R. Dolan

Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma.

Patrick J. Stiff, R. Scott McKenzie, David S. Alberts et al. · Journal of Clinical Oncology · 1994 · 51 citations

Cancer Management, Gynecology, Escalated Bolus Mitoxantrone +18

A Phase II Trial of High-Dose Mitoxantrone, Carboplatin, and Cyclophosphamide with Autologous Bone Marrow Rescue for Recurrent Epithelial Ovarian Carcinoma: Analysis of Risk Factors for Clinical Outcome

Patrick J. Stiff, Robert Bayer, Maria Camarda et al. · Gynecologic Oncology · 1995 · 39 citations

Phase Ii Trial, Medicine, Cancer Management +9

Defining the DNA Substrate Binding Sites on HIV-1 Integrase

James R. Dolan, Aiping Chen, Irene T. Weber et al. · Journal of Molecular Biology · 2008 · 31 citations · Full text

Natural Sciences, Human Retrovirus, Antiviral Response +6

DNA Ploidy, Proliferation Index, Grade, and Stage as Prognostic Factors for Vulvar Squamous Cell Carcinomas

James R. Dolan, Anne R. McCall, Saro Gooneratne et al. · Gynecologic Oncology · 1993 · 21 citations

Prognostic Factors, Vulvar Diseases, Endocrine-related Cancer +9

Does ovarian sex cord tumour with annular tubules produce progesterone?

James R. Dolan, Ali Hassan Al-Timimi, S Richards et al. · Journal of Clinical Pathology · 1986 · 11 citations · Full text

Infertility, Fertility, Cervical Cancer +15